15 小时
Week99er on MSNKeynote 3 Live! BlockDAG Presale Races To $209M Stealing Attention From HBAR & SUI Breakout ...HBAR and SUI show breakout signs, but BlockDAG’s $209M presale and 1,000+ dApp vision make it the top crypto to watch this ...
Trisha Wise-Draper, MD, PhD, discusses anticipated data on head and neck cancers and their potential impact on the field.
Survivorship Care is highlighted, providing emotional, physical, and practical care for patients, along with other positive data to be aware of.
The approval was predicated on Merck and Eisai showing that response rate data was matched by an improvement in survival in a follow-up trial, and that data from the KEYNOTE-775 study has now come in.
BMS is already testing the combo against just Keytruda as a first-line treatment in a Phase III trial in KRAS G12C-mutant and ...
Here’s a look at the top local news stories from Clarksville Now this week, including a verdict in the speeding death trial, ...
The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced ...
3 小时
Daily Democrat on MSNCésar Chávez remembered by Carlos Alcala at Woodland celebrationMany community members gathered at the Woodland Community and Senior Center on Thursday to celebrate and honor the life and ...
The Montgomery County Tennessee Republican Party hosted its 2025 Lincoln Reagan Dinner and Auction Friday night with keynote speaker TV host Elisabeth Hasselbeck.
Pembrolizumab and concurrent CRT, followed by pembrolizumab consolidation, provided long-term tumor control in previously untreated, unresectable, stage III NSCLC.
Personalized Cancer Vaccines Ecosystem Witnessing Positive Transition Driven By Development Of Proprietary Technology Platforms Says Kuick Research. Delhi, March 2 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果